BVH-74318-14333
3 vaccinations
4 coded responses
30 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 701 / LA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-03
- 2021-01-04
- 2021-01-11
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 35, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-09-21
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 7, dose 3MedDRA: Unevaluable event — Feeling: Fair · Joint painsFree text: Right hipMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-28
- 2021-11-02
- 2021-12-21
-
2022-03-22
Survey response — 6 months, dose 3MedDRA: Caesarean section, Emergency care, Pre-eclampsia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Pre eclampsia leading to emergency c sectionMedDRA releases: 2024-11 · check-in free text available
-
2022-03-22
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-03-24
Call successfulDoes not wish to fill out VAERS report
-
2022-09-23
Survey response — 12 months, dose 3MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Flu AMedDRA releases: 2024-11 · check-in free text available
-
2022-09-23
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-21 | Pfizer-BioNTech | No |
Call center
3 call center cases
2 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 35, dose 2
Symptoms: Headache
Release 9 — day 7, dose 3
Systemic reaction (other): Right hip
Release 11 — 6 months, dose 3
Symptoms: Pre eclampsia leading to emergency c section
Release 12 — 12 months, dose 3
Symptoms: Flu A
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release